Saroja Pharma Industries India Ltd Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Standalone - Balance Sheet Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

Fixed Assets

YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024

Investments

YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024

Current Assets

YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024

Compare Balance Sheet Results of Saroja Pharma In

Select Peers

Figures in Cr

Standalone - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

4.02

8.13

-4.11

-50.55%

Share Warrants & Outstandings

Total Reserve

11.66

-6.15

17.81

289.59%

Shareholder's Funds

15.68

1.98

13.70

691.92%

Minority Interest

0.00

0.00%

Long-Term Borrowings

1.38

0.25

1.13

452.00%

Secured Loans

0.40

0.00

0.40

0.00%

Unsecured Loans

0.98

0.25

0.73

292.00%

Deferred Tax Assets / Liabilities

0.01

-0.07

0.08

114.29%

Other Long Term Liabilities

0.00

0.00%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

0.00

0.00%

Total Non-Current Liabilities

1.39

0.18

1.21

672.22%

Current Liabilities

Trade Payables

13.65

0.04

13.61

34,025.00%

Other Current Liabilities

0.77

1.51

-0.74

-49.01%

Short Term Borrowings

8.08

0.00

8.08

0.00%

Short Term Provisions

0.00

0.00%

Total Current Liabilities

22.49

1.55

20.94

1,350.97%

Total Liabilities

39.55

3.72

35.83

963.17%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

2.85

0.21

2.64

1,257.14%

Less: Accumulated Depreciation

0.34

0.21

0.13

61.90%

Less : Impairment of Assets

0.00

0.00%

Net Block

2.51

0.00

2.51

0.00%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

8.61

0.00

8.61

0.00%

Intangible assets under development

0.00

0.00%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

0.34

0.00

0.34

0.00%

Long Term Loans & Advances

0.88

0.37

0.51

137.84%

Other Non Current Assets

0.00

0.00%

Total Non-Current Assets

12.34

0.37

11.97

3,235.14%

Current Assets Loans & Advances

Current Investments

0.00

0.00%

Inventories

0.10

0.02

0.08

400.00%

Sundry Debtors

26.58

0.26

26.32

10,123.08%

Cash and Bank

0.33

0.37

-0.04

-10.81%

Other Current Assets

0.16

0.06

0.10

166.67%

Short Term Loans and Advances

0.05

2.63

-2.58

-98.10%

Total Current Assets

27.22

3.34

23.88

714.97%

Net Current Assets (Including Current Investments)

4.73

1.79

2.94

164.25%

Total Current Assets Excluding Current Investments

27.22

3.34

23.88

714.97%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

39.55

3.72

35.83

963.17%

Contingent Liabilities

0.00

24.34

-24.34

-100.00%

Total Debt

9.46

0.25

9.21

3,684.00%

Book Value per share (adjusted)

38.99

2.43

36.56

1,504.53%

Annual - Borrowings

Borrowings 9.46 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024

Annual - Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets

Fixed Assets 11.12 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024

Annual - Investments

Investments 0.34 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024

Annual - Current Assets

Current Assets 27.22 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024